news

News

Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale

11/14/2024

A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).

A qualitative study involving...

11/14/2024

Psych Congress Network

News

Patient Survey Identifies Barriers to TD Treatment

11/06/2024

Jolynn Tumolo ;

Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.

Key barriers to tardive...

11/06/2024

Psych Congress Network

News

Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response

11/04/2024

Jolynn Tumolo ;

Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...

Adjunctive treatment with the...

11/04/2024

Psych Congress Network

News

Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study

11/01/2024

Brionna Mendoza ;

Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.

Combination...

11/01/2024

Psych Congress Network

a doctor and patient sit on couches talking

News

aLAIs a Useful Treatment Option for Schizophrenia, Study Results Underscore

01/05/2024

Brionna Mendoza ;

Atypical long-acting injectable (aLAI) antipsychotic medications are useful for the treatment of schizophrenia, especially in patients who experienced persistent psychotic symptoms and had trouble maintaining consistent adherence.

Atypical long-acting injectable...

01/05/2024

Psych Congress Network

News

Adding Drug-Drug Interactions, Lifestyle Factors Boosts Pharmacogenomics Guidance

12/04/2023

Jolynn Tumolo ;

Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...

Incorporating drug-drug...

12/04/2023

Psych Congress Network

Conference Poster Highlight

Sleep Disturbances Associated With MDD Recurrence Over 3 Years

10/31/2023

Jolynn Tumolo ;

Hypersomnolence, insomnia, and sleep dissatisfaction predicted the recurrence of MDD over 3 years, according to a poster presentation at Psych Congress.

Hypersomnolence, insomnia, and...

10/31/2023

Psych Congress Network

News

TV-46000 Demonstrates Prolonged Schizophrenia Relapse Prevention, SHINE Study Finds

10/25/2023

Meagan Thistle ;

TV-46000, a long-acting subcutaneous antipsychotic (LASCA), exhibits a favorable long-term benefit-risk profile for patients with schizophrenia, according to study results presented in a poster at Psych Congress 2023.

TV-46000, a long-acting...

10/25/2023

Psych Congress Network

News

TV-46000 Demonstrates Prolonged Schizophrenia Relapse Prevention, SHINE Study Finds

10/25/2023

Meagan Thistle ;

TV-46000, a long-acting...

10/25/2023

Psych Congress Network

Psych Congress Poster Brief

MDD Symptom Improvements With Zuranolone Extend to Daily Lives, Responders Report

10/10/2023

Jolynn Tumolo ;

Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.

Patients with MDD who responded...

10/10/2023

Psych Congress Network

Tracks

Schizophrenia Insights

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.